November 18, 2026 – The ATA announces with pleasure that Anthony Hollenberg, MD, President of Boston Medical Center, began a one-year term as President at the close of the 95th Annual Meeting on November 7th in Philadelphia, Pennsylvania. Secretary Christopher McCabe, PhD, continues as the leader of the ATA’s Board of Directors. Moving to new officer roles on the Board this year are Past President, M. Regina Castro, MD; President-Elect, Matthew Ringel, MD; and Secretary-Elect , Jennifer Sipos, MD.
“Our community is our greatest strength. I look forward to working with all of our members to enhance insight into clinical care, strengthen education about thyroid disease and develop innovative research to meet unmet need in the thyroid field,” said Dr. Tony Hollenberg.
The 17-member Board will also have three new directors, Laura Boucai, MD, Larry Fox, MD, and Julia Noel, MD, and one trainee observer, Jessica Rampy, PhD. Congratulations to all!
ATA thanks the Nominating Committee, chaired by Megan Haymart, MD, and all of the members with a desire to serve in leadership. And ATA recognizes the service of the members who are rotating off the Board of Directors this year: Zubair Baloch, MD, PhD, Maria Cabanillas, MD, Jacqueline Jonklaas, MD, PhD, Kenzie Lee, MD, and David Steward, MD.
Officers
President Anthony Hollenberg, MD, is President of Boston Medical Center. BMC, a premier academic medical center, which models a new kind of excellence in healthcare where clinical and operational innovation meets health equity and access. Before being appointed to this role in 2024, Dr. Hollenberg served as physician-in-chief at Boston Medical Center and the John Wade Professor and Chair of the Department of Medicine at Boston University Chobanian & Avedisian School of Medicine. He has also spent 30-plus years assuming progressive leadership positions in academic medicine at Beth Israel Deaconess Medical Center and Massachusetts General Hospital, before spending four years as the chair and chief of the Department of Medicine at New York-Presbyterian/Weill Cornell. Dr. Hollenberg is a nationally recognized physician-scientist who specializes in endocrinology. His work has focused on thyroid disorders and investigating the physiological and molecular mechanisms by which thyroid hormones regulate metabolism, including body weight, as well as thyroid gland development. Dr. Hollenberg received a medical degree from University of Calgary, and he completed his residency in internal medicine at Beth Israel Deaconess Medical Center, followed by a clinical and research fellowship at Massachusetts General Hospital. Dr. Hollenberg received a Bachelor of Arts in biochemical sciences from Harvard College. He most recently served as President-elect of the ATA and Treasurer of the Association for Professors of Medicine.
President-elect Matthew Ringel, MD, is Professor and Chair of the Department of Molecular Medicine and Therapeutics at The Ohio State University and is the Deputy Director for Basic Research of the OSU Comprehensive Cancer Center and co-director of the Center of Cancer Engineering. He previously served as the Division Director and fellowship director of the OSU Endocrinology division. Dr. Ringel’s research laboratory has defined signaling pathways that regulate thyroid cancer progression and therapeutic resistance and has identified predisposing genes for thyroid cancer. He maintains an active clinical practice and is an elected member of the American Society of Clinical Investigation (ASCI) and the American Association of Physicians (AAP). As a member of the ATA since 1994 he has served on the ATA Board, chaired the research committee, co-chaired the annual meeting, chaired the internet/website task force, and most recently was co-leader of the 2025 ATA thyroid cancer guidelines task force. He has been awarded both the Van Meter and Sidney Ingbar Awards. He has also held leadership roles in the Endocrine Society and ITOG, served and chaired NIH grant review panels, received the NCI Directors service award, and served a term as the Editor-in-Chief of Endocrine-related Cancer.
Secretary-elect Jennifer Sipos, MD, is a Professor of Medicine and Associate Vice Chair for Faculty Affairs for the Department of Medicine at Ohio State University. She also serves as the Medical Director of the Neuroendocrine Cancer Program at The Arthur G. James Comprehensive Cancer Center. She received her medical degree and Internal Medicine residency training at Wake Forest University. She completed her Endocrinology and Metabolism Fellowship at the University of North Carolina in Chapel Hill. Dr. Sipos has developed an interest in the use of ultrasonography for the diagnosis and management of thyroid nodules and cancer and has taught and served as a course director for numerous national and international ultrasound courses. In recognition of her teaching excellence, she was awarded the Hossein Gharib Lectureship sponsored by AACE. She is also actively involved in several clinical research projects with a particular interest in factors implicated in the development of salivary damage after radioiodine therapy, clinical trials for the evaluation of targeted therapies in refractory thyroid cancer, and the diagnostic use of molecular markers in thyroid nodules. She is an invited member of the International Thyroid Nodule Ultrasound Working Group to create an international TIRADS for thyroid nodule ultrasound risk stratification and management. Additionally, she is a member of the writing task force for the ATA Thyroid Nodule Guidelines and a member of the Thyroid Carcinoma Panel of the NCCN Clinical Practice Guidelines.
Directors
Laura Boucai, MD, is a Clinical Member at Memorial Sloan Kettering Cancer Center and an Associate Professor of Clinical Medicine at Weill Cornell Medical College. She graduated from Universidad de Buenos Aires, completed her Internal Medicine Residency at Cornell and an Endocrinology Fellowship at Albert Einstein College of Medicine in New York where she joined the faculty. Her research interests have focused on thyroid cancer biology. She studies the genomic and transcriptomic landscape of thyroid cancer, the role of redifferentiation agents, and the impact of clonal hematopoiesis in thyroid cancer to attempt to find new therapeutic strategies for the most advanced forms of the disease. Dr. Boucai has served multiple roles within the ATA including member of the surgical and clinical affairs committee, member and chair the nominating committee, co-chair of the ATA Spring symposium (2020), co-chair of the ATA Leadership course, chair of Women in Thyroidology (WIT), and is currently a member of the guidelines task and finish group. She is a strong advocate for women, early career members, national and international trainees interested in thyroidology. Her bicultural background and strong commitment to education allows her to bridge knowledge gaps locally and in developing countries with the goal of advancing the care of patients with thyroid disease.
Larry Fox, MD, is Chief of the Division of Endocrinology and Diabetes at Nemours Children’s Health in Jacksonville, Florida, and Professor of Pediatrics at Mayo Clinic School of Medicine. Dr. Fox has dedicated more than three decades to advancing the care of children with thyroid and other endocrine disorders through clinical practice, education, research, and professional service. An ATA member since 2014, Dr. Fox has served on several ATA committees, including the Internet Communications Committee, Public Health Committee, and Program Committee. He chaired the ATA Pediatric Symposium in 2022 and 2023, helping strengthen pediatric engagement and education within the organization. He also contributed to ATA patient education initiatives and online pediatric thyroid resources.
Dr. Fox’s research interests include pediatric thyroid disease, diabetes technology, and growth disorders. He is currently leading efforts to develop a multidisciplinary pediatric thyroid program at Nemours. He has authored more than 85 peer-reviewed publications. In addition, he has been an active committee member and leader within the American Diabetes Association, Pediatric Endocrine Society, and Endocrine Society. He is committed to fostering collaboration across disciplines and promoting the ATA’s mission of advancing thyroid health through excellence in research, education, and patient care.
Julia Noel, MD, is chief of the division of Otolaryngology Head & Neck Surgery at Santa Clara Valley Medical Center and affiliate Associate Professor in the department of Otolaryngology Head & Neck Surgery at the Stanford School of Medicine. Dr. Noel received her medical degree from the University of California in San Diego and completed OHNS residency as well as Head & Neck Endocrine Surgery fellowship at Stanford University. She holds the focused practice designation in Adult Complex Thyroid and Parathyroid Surgery. Dr. Noel has developed a particular interest in thyroid and neck ultrasonography with an emphasis on ultrasound-guided diagnostic and therapeutic procedures. She has served as faculty on numerous ultrasound and thyroid ablation courses and is among the core faculty developing the curriculum for the inaugural Head & Neck and Endocrine Surgery Course through the American Head & Neck Society. She is internationally recognized as an expert in thyroid ablation and maintains an active research program in ablative outcomes and emerging technologies.
As an ATA member she has served on multiple committees including, Surgical Affairs, Trainee and Career Advancement, Program, and Development. She was an author on the ATA’s statement on the safe performance of thyroid ablation published in 2023 and is currently a member of the editorial board of VideoEndocrinology™. She also serves on the editorial board of JAMA Otolaryngology and as an executive council member of the North American Society for Interventional Thyroidology.
Trainee-Observer
Jessica Rampy, PhD, is currently a Postdoctoral Research Fellow Trainee in the Department of Pathology, Microbiology, and Immunology at Vanderbilt University Medical Center. She is also a Vanderbilt Molecular and Genetic Epidemiology of Cancer T32 Training Program Fellow within the Division of Epidemiology, Department of Medicine. Dr. Rampy attended the University of Minnesota, where she graduated summa cum laude with her B.S. in Biochemistry. She then obtained her PhD from Yale University in Cellular & Molecular Physiology. While there, Dr. Rampy completed the highly competitive Medical Research Scholars Program to gain experience and training in translational and clinical settings. Her PhD work, published in The Journal of Clinical Investigation, elucidated novel mechanisms of hypothyroidism brought on by overnutrition including direct impairment of thyroid function and thyroid hormone utilization. She also uncovered notable thyroidal adaptations that occur during overnutrition, which would promote aggressive thyroid cancer. Her current research, using both mouse models and human data, focuses on identifying lifestyle and dietary risk factors for thyroid cancer and on understanding the mechanisms by which obesity exacerbates thyroid cancer in order to identify therapeutic targets and better treatment paradigms. She is also developing her expertise on environmental factors that contribute to thyroid disease.
The American Thyroid Association® (ATA®) is dedicated to transforming thyroid care through clinical excellence, education, scientific discovery, and advocacy in a collaborative community. Founded in 1923, ATA is an international professional medical society with more than 1,700 members from 70 countries around the world.
